Cardiotrophin 1
In-game article clicks load inline without leaving the challenge.
Cardiotrophin-1 (CT-1) is a protein encoded by the CTF1 gene in humans. It functions as a cytokine and acts as a 21.5 kDa cardiac hypertrophic factor. CT-1 belongs to the IL-6 cytokine family.
Tissue distribution
CT-1 is highly expressed in the heart, skeletal muscle, prostate and ovary and to lower levels in lung, kidney, pancreas, thymus, testis and small intestine.
Mode of action
The protein exerts its cellular effects by interacting with the glycoprotein 130 (gp130)/leukemia inhibitory factor receptor beta (LIFR) heterodimer. In addition, CT-1 activates phosphatidylinositol 3-kinase (PI-3 kinase) in cardiac myocytes and enhances transcription factor NF-κB DNA -binding activities.
Clinical significance
CT-1 is associated with the pathophysiology of heart diseases, including hypertension, myocardial infarction, valvular heart disease, and congestive heart failure.
Exogenous administration of CT-1 in rodents has been found to mimic the beneficial effects of exercise on the heart in a rodent model of severe right-sided heart failure.
CT-1 is under formal development for the treatment of reperfusion injury. It is or was also under development for treatment of acute kidney injury, diabetes mellitus, ischemia, liver failure, and obesity, but no recent development for these indications has been reported.
See also
External links
- at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- Irving M (August 8, 2017). . newatlas.com.